BG103096A - Thrombin inhibitors - Google Patents

Thrombin inhibitors

Info

Publication number
BG103096A
BG103096A BG103096A BG10309699A BG103096A BG 103096 A BG103096 A BG 103096A BG 103096 A BG103096 A BG 103096A BG 10309699 A BG10309699 A BG 10309699A BG 103096 A BG103096 A BG 103096A
Authority
BG
Bulgaria
Prior art keywords
thrombin inhibitors
compounds
formulawhere
thetreatment
aswell
Prior art date
Application number
BG103096A
Other languages
Bulgarian (bg)
English (en)
Inventor
Dorit Baucke
Udo Lange
Helmut Mack
Werner Seitz
Thomas Zierke
Hans HOEFFKEN
Wilfried Hornberger
Original Assignee
Basf Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Aktiengesellschaft filed Critical Basf Aktiengesellschaft
Publication of BG103096A publication Critical patent/BG103096A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Indole Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
BG103096A 1996-08-14 1999-01-19 Thrombin inhibitors BG103096A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19632773A DE19632773A1 (de) 1996-08-14 1996-08-14 Neue Thrombininhibitoren
PCT/EP1997/004104 WO1998006741A1 (de) 1996-08-14 1997-07-29 Thrombininhibitoren

Publications (1)

Publication Number Publication Date
BG103096A true BG103096A (en) 1999-09-30

Family

ID=7802624

Family Applications (1)

Application Number Title Priority Date Filing Date
BG103096A BG103096A (en) 1996-08-14 1999-01-19 Thrombin inhibitors

Country Status (30)

Country Link
US (1) US6114358A (sk)
EP (1) EP0956294B1 (sk)
JP (1) JP4089981B2 (sk)
KR (1) KR20000030002A (sk)
CN (1) CN1228783A (sk)
AR (1) AR009070A1 (sk)
AT (1) ATE268781T1 (sk)
AU (1) AU735364B2 (sk)
BG (1) BG103096A (sk)
BR (1) BR9711191A (sk)
CA (1) CA2263220A1 (sk)
CO (1) CO4900030A1 (sk)
CZ (1) CZ299634B6 (sk)
DE (2) DE19632773A1 (sk)
DK (1) DK0956294T3 (sk)
ES (1) ES2221062T3 (sk)
HR (1) HRP970441B1 (sk)
HU (1) HUP0001826A3 (sk)
ID (1) ID17873A (sk)
IL (1) IL127751A0 (sk)
MY (1) MY132820A (sk)
NO (1) NO990662L (sk)
NZ (1) NZ333679A (sk)
PL (1) PL188411B1 (sk)
PT (1) PT956294E (sk)
RU (1) RU2175328C2 (sk)
SK (1) SK284915B6 (sk)
TR (1) TR199900310T2 (sk)
WO (1) WO1998006741A1 (sk)
ZA (1) ZA977239B (sk)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9602263D0 (sv) 1996-06-07 1996-06-07 Astra Ab New amino acid derivatives
SE9602646D0 (sv) 1996-07-04 1996-07-04 Astra Ab Pharmaceutically-useful compounds
DE19632772A1 (de) 1996-08-14 1998-02-19 Basf Ag Neue Benzamidine
DE19632773A1 (de) * 1996-08-14 1998-02-19 Basf Ag Neue Thrombininhibitoren
AR013084A1 (es) 1997-06-19 2000-12-13 Astrazeneca Ab Derivados de amidino utiles como inhibidores de la trombina, composicion farmaceutica, utilizacion de dichos compuestos para la preparacion demedicamentos y proceso para la preparacion de los compuestos mencionados
SE9704543D0 (sv) 1997-12-05 1997-12-05 Astra Ab New compounds
CA2317761A1 (en) * 1998-01-26 1999-07-29 Basf Aktiengesellschaft Thrombin inhibitors
WO1999037611A1 (de) * 1998-01-26 1999-07-29 Basf Aktiengesellschaft Heterocyclische amidine als kallikrein protease inhibitoren
NZ506507A (en) * 1998-02-09 2003-08-29 Dimensional Pharm Inc Heteroaryl amidine, methylamidine or guanidine derivatives useful as urokinase inhibitors
BR9917036A (pt) * 1999-02-09 2002-07-30 Dimensional Pharm Inc Amidinas heteroarila, metilamidinas e guanidinas como inibidores de protease
TR200102912T2 (tr) 1999-04-09 2002-03-21 Basf Ag. Trombin ihtibit”rlerinin ”n ila‡larì.
JP2002541252A (ja) * 1999-04-09 2002-12-03 ビーエーエスエフ アクチェンゲゼルシャフト アミジンの製造
WO2000061608A2 (de) * 1999-04-09 2000-10-19 Basf Aktiengesellschaft Niedermolekulare inhibitoren von komplementproteasen
AR023510A1 (es) 1999-04-21 2002-09-04 Astrazeneca Ab Un equipo de partes, formulacion farmaceutica y uso de un inhibidor de trombina.
KR20010002891A (ko) * 1999-06-18 2001-01-15 성재갑 아릴 또는 헤테로아릴 그룹을 갖는 트롬빈 억제제 및 그 제조 방법
DE19933861A1 (de) * 1999-07-23 2001-01-25 Basf Ag Verfahren zur Herstellung von 2-Aminomethyl-4-cyano-thiazol
DE10049937A1 (de) * 2000-10-06 2002-04-11 Knoll Ag Niedermolekulare Inhibitoren von Serinproteasen mit Polyhydroxyalkyl- und Polyhydroxycycloalkylresten
DE10064797A1 (de) * 2000-12-22 2002-06-27 Knoll Ag Orale und parenterale pharmazeutische Formulierung, umfassend eine niedermolekulare Thrombininhibitor-Pro-Pharmakon
FI122575B (fi) 2006-12-04 2012-03-30 Dieffenbacher Panelboard Oy Laitteisto kuitujen, kuten lastujen sirottelemiseksi
CA2829790C (en) 2010-03-30 2018-06-05 Verseon Corporation Multisubstituted aromatic compounds as inhibitors of thrombin
KR20150130405A (ko) 2013-03-15 2015-11-23 베르선 코포레이션 트롬빈의 억제제로서의 할로게노피라졸
PT2968297T (pt) * 2013-03-15 2019-01-10 Verseon Corp Compostos aromáticos multissubstituídos como inibidores da serina protease
CN103520160B (zh) * 2013-10-17 2015-04-22 广东药学院 三棱中肽类化合物的应用
WO2016044662A1 (en) 2014-09-17 2016-03-24 Verseon Corporation Pyrazolyl-substituted pyridone compounds as serine protease inhibitors
ES2931460T3 (es) 2015-02-27 2022-12-29 Verseon Int Corporation Compuestos de pirazol sustituido como inhibidores de serina proteasa

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU675981B2 (en) * 1992-12-02 1997-02-27 Bristol-Myers Squibb Company Guanidinyl-substituted heterocyclic thrombin inhibitors
SE9301916D0 (sv) * 1993-06-03 1993-06-03 Ab Astra New peptides derivatives
EP0648780A1 (en) * 1993-08-26 1995-04-19 Bristol-Myers Squibb Company Heterocyclic thrombin inhibitors
ZA951617B (en) * 1994-03-04 1997-02-27 Lilly Co Eli Antithrombotic agents.
DE4421052A1 (de) * 1994-06-17 1995-12-21 Basf Ag Neue Thrombininhibitoren, ihre Herstellung und Verwendung
NZ302649A (en) * 1995-02-17 2000-01-28 Basf Ag Dipeptide amidine derivatives, preparation and pharmaceutical compositions thereof
DE19632772A1 (de) * 1996-08-14 1998-02-19 Basf Ag Neue Benzamidine
DE19632773A1 (de) * 1996-08-14 1998-02-19 Basf Ag Neue Thrombininhibitoren

Also Published As

Publication number Publication date
AU3941797A (en) 1998-03-06
IL127751A0 (en) 1999-10-28
HRP970441A2 (en) 1998-06-30
NZ333679A (en) 1999-09-29
CZ299634B6 (cs) 2008-10-01
JP4089981B2 (ja) 2008-05-28
WO1998006741A1 (de) 1998-02-19
HRP970441B1 (en) 2005-04-30
JP2000516598A (ja) 2000-12-12
ZA977239B (en) 1999-02-15
MY132820A (en) 2007-10-31
DK0956294T3 (da) 2004-10-11
ATE268781T1 (de) 2004-06-15
RU2175328C2 (ru) 2001-10-27
CO4900030A1 (es) 2000-03-27
ES2221062T3 (es) 2004-12-16
PT956294E (pt) 2004-10-29
NO990662D0 (no) 1999-02-12
PL188411B1 (pl) 2005-01-31
SK284915B6 (sk) 2006-02-02
CA2263220A1 (en) 1998-02-19
CZ48699A3 (cs) 1999-05-12
DE59711714D1 (de) 2004-07-15
US6114358A (en) 2000-09-05
EP0956294A1 (de) 1999-11-17
HUP0001826A3 (en) 2002-01-28
SK899A3 (en) 1999-06-11
PL331540A1 (en) 1999-07-19
EP0956294B1 (de) 2004-06-09
KR20000030002A (ko) 2000-05-25
TR199900310T2 (xx) 1999-04-21
ID17873A (id) 1998-02-05
AU735364B2 (en) 2001-07-05
NO990662L (no) 1999-02-12
BR9711191A (pt) 1999-08-17
CN1228783A (zh) 1999-09-15
DE19632773A1 (de) 1998-02-19
AR009070A1 (es) 2000-03-08
HUP0001826A2 (hu) 2000-09-28

Similar Documents

Publication Publication Date Title
BG103096A (en) Thrombin inhibitors
MX9706069A (es) Nuevos inhibidores de la trombina.
BG102425A (en) (methylsulphonyl)phenyl-2-(5h)-furanons as cyclooxygenase-2-inhibitors
BG104056A (en) Triazole compounds and their use as dopamine-d3-ligands
MX9603831A (es) Agentes antitromboticos.
BG105783A (en) Triazole compounds with dopamine-d3-receptor affinity
TR200001603T2 (tr) Yeni bileşikler
BG103310A (en) Benzonaphthyridins as bronchial therapeutical means
MX9606521A (es) Inhibidores de trombina novedosos, preparacion y uso de los mismos.
MX9702658A (es) Derivados novedosos de acido carboxilico, su preparacion y uso.
MX9700886A (es) Nuevas oxazolidinonas sustituidas.
BG101112A (en) The use of heterocyclic compounds
IL112495A0 (en) Phenylacetic acid derivatives, their preparation and compositions containing them
MY115662A (en) Novel compounds with analgesic effect
GR3023233T3 (en) Inhibitors of dipeptidyl-aminopeptidase type iv
MY107158A (en) 3-arylcarbonyl; -1h-indoles useful as therapeutic agents.
MX9704030A (es) 1,1-dioxidos de 2-heterocicliloxi y tiometil-1,2,5-tiadiazolidin-3-ona y composiciones y metodo de uso de los mismos.
MY106202A (en) Saccharin derivatives useful as proteolytic enzyme inhibitors and preparation thereof.
BG103219A (en) Benzamidine derivatives and their application as medicamentous forms with ltb-4-antagonist effect
MX9804588A (es) Uso de composiciones que comprenden blanqueador de halogeno para suavidad mejorada a la piel.
EP0793660A4 (en) 2-SUBSTITUTED 1,2,5-THIADIAZOLIDIN-3-ON-1,1-DIOXIDES, COMPOSITION AND THEIR USE
ES8801243A1 (es) Procedimiento para la obtencion de medicamentos que contienen 1-heteroaril-4--aril-pirazolin-5-onas.
BG103558A (en) Sulphonic acid or sulphonylamino n-(heteroaralkyl)-azaheterocyclylamide compounds
MX9704050A (es) P-amidinobencilamidas de dipeptido novedosas con radicales sulfonilo o aminosulfonilo en terminal n.
UA49884C2 (uk) ПОХІДНІ <font face="Symbol">a</font>-ГІДРОКСИКАРБОНОВОЇ КИСЛОТИ ТА ЛІКАРСЬКИЙ ЗАСІБ НА ЇХ ОСНОВІ